To determine whether similar effects occur in endometrial cancer, we treated HEC-1A, RL95-2, and ECC-1 cells with baicalein at concentrations ranging from 2.5 to 80 μM for various durations and analyzed the expression of DDIT4 and IRF-1. Here, IRF1 is linked to endometrial cancer.